Pharmacists' Expanding Role in MASLD Screening and Care
Pharmacist Susan Cornell discusses the critical role pharmacists play in identifying and managing metabolic dysfunction-associated steatotic liver disease (MASLD). She emphasizes screening for risk factors like obesity and diabetes and highlights the importance of lifestyle changes alongside new medication options.
Why it matters
As MASLD is often silent, pharmacist-led screening can lead to earlier diagnosis and better management of this prevalent liver condition.
In an interview with Pharmacy Times, Susan Cornell, PharmD, CDCES, FAPhA, FADCES, professor emeritus and experiential education specialist at Midwestern University College of Pharmacy, discussed the pharmacist's role in identifying and managing metabolic dysfunction–associated steatotic liver disease (MASLD). Based on her presentation at the 2026 Association of Diabetes Care and Education Specialists Annual Meeting, she explained that MASLD—fat in the liver—is often silent but can progress to inflammation, fibrosis, and metabolic dysfunction-associated steatohepatitis (MASH).
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in